scholarly article | Q13442814 |
P50 | author | Hiroyuki Yoda | Q64826753 |
P2093 | author name string | Hirokazu Sugimoto | |
Hiroki Nagase | |||
Kiriko Hiraoka | |||
Kyoko Fujiwara | |||
Meixiang Sang | |||
Mizuyo Nakamura | |||
Toshinori Ozaki | |||
P2860 | cites work | The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage | Q22010200 |
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage | Q22010201 | ||
The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation | Q24746257 | ||
Surfing the p53 network | Q28032484 | ||
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis | Q28138604 | ||
The RUNX genes: gain or loss of function in cancer | Q28247901 | ||
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis | Q28273478 | ||
An anti-apoptotic role for the p53 family member, p73, during developmental neuron death | Q28505615 | ||
p73 is transcriptionally regulated by DNA damage, p53, and p73 | Q73787650 | ||
Effect of Recombinant Human Bone Morphogenetic Protein-2 on Fracture Healing in a Goat Tibial Fracture Model | Q77301876 | ||
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family | Q81662172 | ||
Causal relationship between the loss of RUNX3 expression and gastric cancer | Q28509530 | ||
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
Live or let die: the cell's response to p53 | Q29547663 | ||
Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers | Q29616471 | ||
p53 family genes: structural comparison, expression and mutation | Q30833177 | ||
The p53 pathway | Q33643359 | ||
The cellular response to p53: the decision between life and death | Q33771774 | ||
The genetic transformation of bone biology | Q33796568 | ||
Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter | Q34277205 | ||
p53 function and dysfunction | Q35721291 | ||
Runx protein signaling in human cancers | Q35785021 | ||
Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures | Q36293998 | ||
Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice | Q36635990 | ||
Mutant p53 proteins: between loss and gain of function | Q36661775 | ||
Mutant p53: an oncogenic transcription factor | Q36777355 | ||
RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes | Q37013889 | ||
ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia | Q37077053 | ||
Runx family genes, niche, and stem cell quiescence | Q37690010 | ||
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer | Q38298230 | ||
Role of the p53-homologue p73 in E2F1-induced apoptosis | Q38306110 | ||
Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage | Q39160361 | ||
Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor | Q39384202 | ||
Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells | Q39996177 | ||
p53: at the crossroads of molecular carcinogenesis and risk assessment | Q40793098 | ||
Role for the p53 homologue p73 in E2F-1-induced apoptosis | Q40848736 | ||
p73 is a simian [correction of human] p53-related protein that can induce apoptosis | Q41091013 | ||
Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance | Q41314252 | ||
p73 can suppress the proliferation of cells that express mutant p53. | Q44633578 | ||
Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. | Q45094169 | ||
p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement. | Q45862633 | ||
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. | Q50320380 | ||
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development | Q52111650 | ||
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation | Q52541271 | ||
Ex vivo expansion, adipogenesis and neurogenesis of cryopreserved human bone marrow mesenchymal stem cells | Q53574563 | ||
Runx2 in human breast carcinoma: its potential roles in cancer progression | Q54643065 | ||
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer | Q58436097 | ||
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage | Q59065672 | ||
A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc | Q73270837 | ||
Chemosensitivity linked to p73 function | Q73342473 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
DNA damage | Q5205747 | ||
apoptotic process | Q14599311 | ||
P304 | page(s) | 114-128 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity | |
P478 | volume | 282 |
Q38885306 | Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling |
Q37687744 | Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63. |
Q40975866 | Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63. |
Q64279445 | Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies |
Q52646480 | Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations |
Q42419195 | Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death |
Q26777988 | Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2 |
Q90375158 | RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells |
Q47944350 | Roles of RUNX in Hippo Pathway Signaling. |
Q37167523 | Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. |
Q38827698 | Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. |
Q33720222 | TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3 |
Q37688091 | miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors |
Q42492256 | p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity |
Search more.